The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Deferiprone targets aconitase: Implication for Friedreich's ataxia treatment
Open accessAbstract
Background: Friedreich ataxia is a neurological disease originating from an iron-sulfur cluster enzyme deficiency due to impaired iron handling in the mitochondrion, aconitase being particularly affected. As a mean to counteract disease progression, it has been suggested to chelate free mitochondrial iron. Recent years have witnessed a renewed interest in this strategy because of availability of deferiprone, a chelator preferentially targeting mitochondrial iron. Method: Control and Friedreich's ataxia patient cultured skin fibroblasts, frataxin-depleted neuroblastoma-derived cells (SK-N-AS) were studied for their response to iron chelation, with a particular attention paid to iron-sensitive aconitase activity. Results: We found that a direct consequence of chelating mitochondrial free iron in various cell systems is a concentration and time dependent loss of aconitase activity. Impairing aconitase activity was shown to precede decreased cell proliferation. Conclusion: We conclude that, if chelating excessive mitochondrial iron may be beneficial at some stage of the disease, great attention should be paid to not fully deplete mitochondrial iron store in order to avoid undesirable consequences.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“appropriate iron chelation may have therapeutic benefits”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion
Campuzano, V., Montermini, L., Moltò, M. D., Pianese, L., Cossée, M., Cavalcanti, F., Monros, E., Rodius, F., Duclos, F., Monticelli, A., et al. (1996) · Science · doi:10.1126/science.271.5254.1423 · Cited by 2,786 · cited 1×
“It originates from a triplet expansion in the first intron of the gene coding for frataxin and the resulting impaired transcription causes depletion of this mitochondrial protein [1].”
BackgroundHentze, M. W., & Kühn, L. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8175 · Cited by 1,292
Aconitase and mitochondrial iron–sulphur protein deficiency in Friedreich ataxia
Rötig, A., de Lonlay, P., Chretien, D., Foury, F., Koenig, M., Sidi, D., Munnich, A., & Rustin, P. (1997) · Nature Genetics · doi:10.1038/ng1097-215 · Cited by 991
Self-citationSelective iron chelation in Friedreich ataxia: biologic and clinical implications
Boddaert, N., Le Quan Sang, K. H., Rötig, A., Leroy-Willig, A., Gallet, S., Brunelle, F., Sidi, D., Thalabard, J.-C., Munnich, A., & Cabantchik, Z. I. (2007) · Blood · doi:10.1182/blood-2006-12-065433 · Cited by 409
Wong, A. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.3.425 · Cited by 374 · cited 1×
“Conflicting results have been reported concerning mitochondrial iron content of FRDA patient's fibroblasts which may or not accumulate iron [16].”
BackgroundDi Prospero, N. A., Baker, A., Jeffries, N., & Fischbeck, K. H. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70220-x · Cited by 300
Glickstein, H., Ben El, R., Shvartsman, M., & Cabantchik, Z. I. (2005) · Blood · doi:10.1182/blood-2005-02-0460 · Cited by 249
Disabled early recruitment of antioxidant defenses in Friedreich's ataxia
Chantrel-Groussard, K. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.19.2061 · Cited by 189
Self-citationMetabolic regulation of citrate and iron by aconitases: role of iron–sulfur cluster biogenesis
Tong, W.-H., & Rouault, T. A. (2007) · BioMetals · doi:10.1007/s10534-006-9047-6 · Cited by 160
Characterization of Iron-Sulfur Protein Assembly in Isolated Mitochondria
Mühlenhoff, U., Richhardt, N., Gerber, J., & Lill, R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204675200 · Cited by 125
Research works printed but not linked: 1
- Tzagoloff A: Mitochondria. Cellular Organelles. Edited by: Siekevitz P. 1982, New York , Plenum Press, 1-342.
Cited by
Kell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361
Scott, L. E., & Orvig, C. (2009) · Chemical Reviews · doi:10.1021/cr9000176 · Cited by 332
Importance of Iron Chelation in Free Radical-Induced Oxidative Stress and Human Disease
Jomova, K., & Valko, M. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798072463 · Cited by 271
Impaired Nuclear Nrf2 Translocation Undermines the Oxidative Stress Response in Friedreich Ataxia
Paupe, V., Dassa, E. P., Goncalves, S., Auchère, F., Lönn, M., Holmgren, A., & Rustin, P. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004253 · Cited by 218
Self-citationFriedreich Ataxia: Molecular Mechanisms, Redox Considerations, and Therapeutic Opportunities
Santos, R., Lefevre, S., Sliwa, D., Seguin, A., Camadro, J.-M., & Lesuisse, E. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.3015 · Cited by 192
Metadata
- Authors
- Goncalves, S., Paupe, V., Dassa, E. P., & Rustin, P.
- Affiliations
- Inserm (FR)
- Corresponding author
- Rustin, Pierre
- ORCID
- Rustin, Pierre
- Venue
- BMC Neurology
- Published
- 2008-06-16
- Volume
- 8
- Issue
- 1
- Pages
- 20-20
- ISSN
- 1471-2377 (ISSN-L)
- PMC
- PMC2440763
- OpenAlex
- W2080445232
- Cited by
- 66
- References
- 17
- Citations by year
- 2025: 2 · 2024: 1 · 2023: 5 · 2022: 3 · 2020: 5 · 2019: 5 · 2018: 3 · 2017: 5 · 2016: 1 · 2015: 2 · 2014: 3 · 2013: 6 · 2012: 2
- FWCI
- 5.03
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- BMC Neurology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Friedreich's Ataxia Research Alliance
- Fund for Astrophysical Research
- Topics
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- Friedreich's ataxia, deferiprone, aconitase, iron chelation, mitochondrial iron, frataxin, cell proliferation, neurodegeneration
- MeSH terms
- Deferiprone, Aconitate Hydratase, Cells, Cultured, Cytosol, Fibroblasts, Friedreich Ataxia, Humans, Iron, Iron Chelating Agents, Mitochondria, Pyridones, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Deferiprone targets aconitase: Implication for Friedreich's ataxia treatment. https://app.cochat.ai/papers/10.1186/1471-2377-8-20
- The paper
- Goncalves, S., Paupe, V., Dassa, E. P., & Rustin, P. (2008). Deferiprone targets aconitase: Implication for Friedreich's ataxia treatment. BMC Neurology. https://doi.org/10.1186/1471-2377-8-20
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.